| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 113.43▲ | 113.31▲ | 113.38▲ | 112.81▲ | 112.59▲ |
| MA10 | 113.33▲ | 113.39▲ | 113.11▲ | 112.82▲ | 111.67▲ |
| MA20 | 113.27▲ | 112.91▲ | 112.62▲ | 112.02▲ | 111.21▲ |
| MA50 | 113.34▲ | 112.76▲ | 112.85▲ | 110.93▲ | 115.66▼ |
| MA100 | 113.08▲ | 112.91▲ | 112.83▲ | 110.99▲ | 103.95▲ |
| MA200 | 112.54▲ | 112.76▲ | 110.71▲ | 115.72▼ | 90.08▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.050▲ | 0.040▲ | 0.152▲ | 0.045▲ | 0.447▲ |
| RSI | 56.719▲ | 60.746▲ | 58.108▲ | 55.872▲ | 51.653▲ |
| STOCH | 75.942 | 50.478 | 83.615▲ | 55.027 | 63.524 |
| WILL %R | -24.490▲ | -20.472▲ | -9.420▲ | -27.644 | -23.377▲ |
| CCI | 123.902▲ | 57.914 | 68.843 | 71.112 | 65.564 |
|
Thursday, November 14, 2019 09:34 AM
INDIANAPOLIS, Ind. (Inside INdiana Business) – Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and Germany-based Boehringer Ingelheim are launching EMPULSE, the sixth phase III study in the Jardiance ...
|
|
Thursday, November 14, 2019 05:07 AM
Eli Lilly And Co (NYSE: LLY) and Boehringer Ingelheim said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 14-2 against the approval of their empagliflozin 2.5mg as an adjunct to ...
|
|
Tuesday, November 12, 2019 05:04 AM
Eli Lilly (NYSE:LLY) announces positive results from a Phase 3b/4 clinical trial, SPIRIT-Head-to-Head, comparing Taltz (ixekizumab) to AbbVie's (NYSE:ABBV) Humira (adalimumab) in biologic-naïve ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/11/19 | 113.08 | 113.70 | 112.90 | 113.52 | 598,214 |
| 15/11/19 | 111.33 | 113.82 | 111.33 | 113.19 | 4,857,400 |
| 14/11/19 | 112.19 | 112.36 | 111.00 | 111.39 | 2,627,100 |
| 13/11/19 | 112.87 | 113.53 | 112.25 | 112.79 | 3,250,600 |
| 12/11/19 | 112.77 | 114.04 | 112.45 | 113.17 | 2,273,200 |
| 11/11/19 | 113.46 | 114.21 | 112.22 | 112.80 | 1,770,200 |
| 08/11/19 | 112.65 | 113.57 | 112.10 | 113.53 | 2,224,100 |
| 07/11/19 | 114.23 | 114.63 | 112.03 | 112.77 | 3,076,200 |
| 06/11/19 | 111.57 | 114.29 | 111.51 | 113.82 | 3,973,700 |
| 05/11/19 | 112.95 | 113.08 | 110.51 | 111.25 | 3,144,748 |
|
|
||||
|
|
||||
|
|